Literature DB >> 32175378

Preoperative prediction of hepatocellular carcinoma with highly aggressive characteristics using quantitative parameters derived from hepatobiliary phase MR images.

Zheng Ye1, Likun Cao1,2, Yi Wei1, Jie Chen1, Zhen Zhang1, Shan Yao1, Ting Duan3, Bin Song3.   

Abstract

BACKGROUND: To prospectively determine whether the quantitative imaging parameters derived from the hepatobiliary phase (HBP) can be used for the preoperative prediction of hepatocellular carcinoma (HCC) with highly aggressive characteristics.
METHODS: One hundred and three patients with surgical-proven HCC were included from July 2015 to June 2018. Two independent reviewers measured signal intensity (SI) of liver and tumor, and quantitative parameters, including relative tumor enhancement (RTE), tumor to liver contrast ratio (TLR), tumor enhancement index (TEI), and relative enhancement ratio (RER) were calculated. The aggressive characteristics of HCC were identified by using the Ki-67 labeling index (LI), and patients were classified into low aggressive (Ki-67 LI ≤10%) and high aggressive (Ki-67 LI >10%) groups. The difference of quantitative parameters between two groups was assessed, and the correlation between quantitative parameters and Ki-67 LI was explored. Receiver operating characteristic analyses was used to evaluate the predictive performance of quantitative parameters.
RESULTS: The values of RTE, TLR, TEI, and RER, were significantly lower in the highly aggressive group than low aggressive group (P<0.05), and negative correlations were obtained between these quantitative parameters and Ki-67 LI (r ranges from -0.41 to -0.22, P<0.05). TLR demonstrated the highest predictive performance with the area under curve (AUC) of 0.83 [95% confidence interval (CI): 0.75-0.90], sensitivity of 89.0% and specificity of 63.3%, and subsequent with RER, TEI, and RTE with AUC of 0.78 (95% CI: 0.68-0.85), 0.74 (95% CI: 0.64-0.82) and 0.68 (95% CI: 0.58-0.77), respectively. Good inter-observer and intra-observer agreement were found in all parameters.
CONCLUSIONS: TLR showed the highest predictive performance in highly aggressive HCC. Quantitative parameters based on HBP could preoperatively predict the aggressiveness of HCC. 2020 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); Ki-67 antigen; hepatobiliary phase (HBP); quantitative analysis; sensitivity and specificity

Year:  2020        PMID: 32175378      PMCID: PMC7049034          DOI: 10.21037/atm.2020.01.04

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  24 in total

1.  Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

Authors:  Yong-Fa Zhang; Rong-Ping Guo; Ru-Hai Zou; Jing-Xian Shen; Wei Wei; Shao-Hua Li; Han-Yue OuYang; Hong-Bo Zhu; Li Xu; Xiang-Ming Lao; Ming Shi
Journal:  Eur Radiol       Date:  2015-09-22       Impact factor: 5.315

2.  Quantitative analysis of gadoxetic acid-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma.

Authors:  Hong-Fei Tong; Hong-Bo Liang; Zhi-Kang Mo; Tian-Pei Guan; Jian Yang; Chi-Hua Fang
Journal:  Clin Imaging       Date:  2017-01-11       Impact factor: 1.605

3.  Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma.

Authors:  Y Li; C Yan; S Weng; Z Shi; H Sun; J Chen; X Xu; R Ye; J Hong
Journal:  Clin Radiol       Date:  2019-07-27       Impact factor: 2.350

4.  Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index.

Authors:  Xin-Xing Hu; Zhao-Xia Yang; He-Yue Liang; Ying Ding; Robert Grimm; Cai-Xia Fu; Hui Liu; Xu Yan; Yuan Ji; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  J Magn Reson Imaging       Date:  2016-11-10       Impact factor: 4.813

5.  Local modalities for inoperable hepatocellular carcinoma: radiofrequency ablation versus stereotactic body radiotherapy.

Authors:  Sun Hyun Bae; Hee Chul Park
Journal:  Ann Transl Med       Date:  2018-11

6.  Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.

Authors:  Julien Calderaro; Gabrielle Couchy; Sandrine Imbeaud; Giuliana Amaddeo; Eric Letouzé; Jean-Frédéric Blanc; Christophe Laurent; Yacine Hajji; Daniel Azoulay; Paulette Bioulac-Sage; Jean-Charles Nault; Jessica Zucman-Rossi
Journal:  J Hepatol       Date:  2017-05-19       Impact factor: 25.083

Review 7.  Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

Authors:  Kristina I Ringe; Daniela B Husarik; Claude B Sirlin; Elmar M Merkle
Journal:  AJR Am J Roentgenol       Date:  2010-07       Impact factor: 3.959

8.  Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.

Authors:  Sachiyo Kogita; Yasuharu Imai; Masahiro Okada; Tonsok Kim; Hiromitsu Onishi; Manabu Takamura; Kazuto Fukuda; Takumi Igura; Yoshiyuki Sawai; Osakuni Morimoto; Masatoshi Hori; Hiroaki Nagano; Kenichi Wakasa; Norio Hayashi; Takamichi Murakami
Journal:  Eur Radiol       Date:  2010-05-19       Impact factor: 5.315

9.  The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma.

Authors:  Stephan R Vavricka; Diana Jung; Michael Fried; Uwe Grützner; Peter J Meier; Gerd A Kullak-Ublick
Journal:  J Hepatol       Date:  2004-02       Impact factor: 25.083

10.  Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study.

Authors:  Zheng Ye; Hanyu Jiang; Jie Chen; Xijiao Liu; Yi Wei; Chunchao Xia; Ting Duan; Likun Cao; Zhen Zhang; Bin Song
Journal:  Chin J Cancer Res       Date:  2019-10       Impact factor: 5.087

View more
  2 in total

1.  Preoperative radiomics model using gadobenate dimeglumine-enhanced magnetic resonance imaging for predicting β-catenin mutation in patients with hepatocellular carcinoma: A retrospective study.

Authors:  Fengxia Zeng; Hui Dai; Xu Li; Le Guo; Ningyang Jia; Jun Yang; Danping Huang; Hui Zeng; Weiguo Chen; Ling Zhang; Genggeng Qin
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

Review 2.  Hyperpolarized carbon 13 MRI in liver diseases: Recent advances and future opportunities.

Authors:  Zheng Ye; Bin Song; Philip M Lee; Michael A Ohliger; Christoffer Laustsen
Journal:  Liver Int       Date:  2022-03-12       Impact factor: 8.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.